Analyst Ratings for iTeos Therapeutics (ITOS)
ITOS Rating Summary
ITOS Price Target Summary
- Highest: $11.00 (Wells Fargo)
- Lowest: $10.00 (Leerink Partners)
- Average: $10.35
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$10.35 (+2%)
* Over Last 12-Mos
Rating Score: 1.4 / 10
Percentile Rank: 10%
Avg. $ Target:
$10.35 (+2%)
* Over Last 12-Mos
Rating Score: 1.4 / 10
Percentile Rank: 10%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/21/2025 | Piper Sandler | Edward A. Tenthoff | Downgrade | Neutral (Overweight) |
10.05 (N/A) |
10.26 (10.15) |
-1.07% | Details |
| 5/28/2025 | Wells Fargo » Updated 8/7/2025 |
Eva Fortea Verdejo | Downgrade | Equal Weight (Overweight) |
11.00 (12.00) |
8.53 (10.15) |
18.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
